These findings not only elucidate the complex regulatory mechanisms of TP53 within the tumor immune microenvironment but also suggest that TP53 and its associated regulatory pathways may serve as potential therapeutic strategies for specific cancer types. The gene discussed is TP53; the disease is cancer.